View in EDS HTML Full Text PDF Full Text

Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey.

Saved in:
Bibliographic Details
Title: Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey.
Authors: Cleland JGF (AUTHOR), Cohen-Solal A (AUTHOR), Aguilar JC (AUTHOR), Dietz R (AUTHOR), Eastaugh J (AUTHOR), Follath F (AUTHOR), Freemantle N (AUTHOR), Gavazzi A (AUTHOR), van Gilst WH (AUTHOR), Hobbs FDR (AUTHOR), Korewicki J (AUTHOR), Madeira HC (AUTHOR), Preda I (AUTHOR), Swedberg K (AUTHOR), Widimsky J (AUTHOR), IMPROVEMENT of Heart Failure Programme Committees and Investigators (CORPORATE AUTHOR), European Society of Cardiology. Working Group on Heart Failure. Study Group on Diagnosis (CORPORATE AUTHOR), Cleland, J G F (AUTHOR), Cohen-Solal, A (AUTHOR), Aguilar, J Cosin (AUTHOR)
Source: Lancet. 11/23/2002, Vol. 360 Issue 9346, p1631-1639. 9p.
Abstract: Background: Heart failure is a prevalent condition that is generally treated in primary care. The aim of this study was to assess how primary-care physicians think that heart failure should be managed, how they implement their knowledge, and whether differences exist in practice between countries.Methods: The survey was undertaken in 15 countries that had membership of the European Society of Cardiology (ESC) between Sept 1, 1999, and May 31, 2000. Primary-care physicians' knowledge and perceptions about the management of heart failure were assessed with a perception survey and how a representative sample of patients was managed with an actual practice survey.Findings: 1363 physicians provided data for 11062 patients, of whom 54% were older than 70 years and 45% were women. 82% of patients had had an echocardiogram but only 51% of these showed left ventricular systolic dysfunction. Ischaemic heart disease, hypertension, diabetes mellitus, atrial fibrillation, and major valve disease were all common. Physicians gave roughly equal priority to improvement of symptoms and prognosis. Most were aware of the benefits of ACE inhibitors and beta blockers. 60% of patients were prescribed ACE inhibitors, 34% beta blockers but only 20% received these drugs in combination. Doses given were about 50% of targets suggested in the ESC guidelines. If systolic dysfunction was documented, ACE inhibitors were more likely and beta blockers less likely to be prescribed than when there was no evidence of systolic dysfunction.Interpretation: Results from this survey suggest that most patients with heart failure are appropriately investigated, although this finding might be as a result of high rates of hospital admissions. However, treatment seems to be less than optimum, and there are substantial variations in practice between countries. The inconsistencies between physicians' knowledge and the treatment that they deliver suggests that improved organisation of care for heart failure is required. [ABSTRACT FROM AUTHOR]
Copyright of Lancet is the property of Lancet and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first